Performance of existing risk scores in screening for undiagnosed diabetes: An external validation study

Diabetic Medicine

Volumn 27, Issue 1, 2010, Pages 46-53

  Witte, D R ^a   Shipley, M J ^b   Marmot, M G ^b   Brunner, E J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

Risk prediction; Screening; Undiagnosed diabetes; Validation

Indexed keywords

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; VALIDATION PROCESS;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONDON; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 73949126535     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02891.x     Document Type: Article

References (39)

1. Masso-Gonzalez EL, Johansson S, Wallander MA, Garcia-Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK - 1996 to 2005. J Epidemiol Community Health 2009 63 : 332 336.
2. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000 23 : 1563 1580.
3. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997 20 : 491 496.
4. Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004 27 : 727 733.
5. Holt TA, Stables D, Hippisley-Cox J, O'Hanlon S, Majeed A. Identifying undiagnosed diabetes: cross-sectional survey of 3.6 million patients' electronic records. Br J Gen Pract 2008 58 : 192 196.
6. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998 352 : 854 865.
7. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998 317 : 703 713.
8. Department of Health. National Service Framework for Diabetes. London : Department of Health, 2009.
9. Department of Health. Five Years On. Delivering the Diabetes National Service Framework. London : Department of Health, 2008.
10. Department of Health. Vascular Programme - Putting Prevention First. Vascular Checks: Risk Assessment and Management. London : Department of Health, 2009.
11. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007 11 : iii xi.
12. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995 18 : 382 387.
13. Rolka DB, Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K et al. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 2001 24 : 1899 1903.
14. ADA. Diabetes Risk Test. American Diabetes Association, 2004. Available at http://www.diabetes.org/diabetes-basics/prevention/diabetes-risk-test/ Last accessed 3 December 2009.
15. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003 26 : 725 731.
16. Finnish Diabetes Association. Risk Assessment Form. Finnish Diabetes Association, 2004. Available at http://www.diabetes.fi/tiedoston-katsominen.php? dok-id=567 Last accessed 3 December 2009.
17. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ et al. Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 1999 22 : 213 219.
18. Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diabetes Care 2004 27 : 367 371.
19. Welborn TA. ADS Position Statements: Screening for Non-Insulin Dependent Diabetes. Australian Diabetes Society, 1996. Available at http://www. diabetessociety.com.au/downloads/positionstatements/screening.pdf Last accessed 3 December 2009.
20. Colagiuri S, Zimmet P, Hepburn A, Colagiuri R, eds. National Evidence- Based Guidelines for the Management of Type 2 Diabetes Mellitus. Sydney, Australia : Australian Centre for Diabetes Strategies, 2002.
21. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva : World Health Organization, 1968.
22. Bleeker SE, Moll HA, Steyerberg EW, Donders AR, Derksen-Lubsen G, Grobbee DE et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol 2003 56 : 826 832.
23. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991 337 : 1387 1393.
24. Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M et al. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 1997 40 : 1341 1349.
25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 15 : 539 553.
26. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000 16 : 164 171.
27. Park PJ, Griffin SJ, Sargeant L, Wareham NJ. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 2002 25 : 984 988.
28. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva : World Health Organisation, 1968.
29. Davies MJ, Ammari F, Sherriff C, Burden ML, Gujral J, Burden AC. Screening for Type 2 diabetes mellitus in the UK Indo-Asian population. Diabet Med 1999 16 : 131 137.
30. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982 143 : 29 36.
31. Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De LA et al. Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 2008 24 : 511 519.
32. 1c assay in the diagnosis of diabetes. Diabetes Care 2009 32 : 1327 1334.
33. Glümer C, Jørgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003 26 : 2335 2340.
34. Centers for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2003 52 : 833 837.
35. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 : 1414 1431.
36. Brenner H, Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat Med 1997 16 : 981 991.
37. Glümer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006 29 : 410 414.
38. Spijkerman A, Griffin S, Dekker J, Nijpels G, Wareham NJ. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. J Med Screen 2002 9 : 187 190.
39. Spijkerman AM, Yuyun MF, Griffin SJ, Dekker JM, Nijpels G, Wareham NJ. The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care 2004 27 : 116 122.